Prostate-specific antigen testing in Australia and association with prostate cancer incidence in New South Wales

Medical Journal of Australia

Volumn 169, Issue 1, 1998, Pages 17-20

  Smith, David P ^a,b   Armstrong, Bruce K ^a  

^a CANCER RESEARCH DIVISION   (Australia)

^b Epidemiology Research Unit   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; AUSTRALIA; CANCER SCREENING; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER;

EID: 0032490637     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1998.tb141471.x     Document Type: Article

References (23)

1. Coates M, Armstrong B. Cancer in New South Wales. Incidence and mortality 1994. Sydney: NSW Cancer Council, 1997.
2. South Australian Cancer Registry. Epidemiology of cancer in South Australia. Incidence, mortality and survival 1977 to 1996, incidence and mortality 1996 analysed by type and geographical location. Twenty years of data. Adelaide: South Australian Health Commission, 1997.
3. Australian Bureau of Statistics. Causes of death, Australia, 1995. Canberra: AGPS, 1996. (Catalogue No. 3303.0.)
4. Threlfall T, Whitford M, Thompson J. Cancer incidence and mortality in Western Australia 1992 to 1994. A report of the Western Australian Cancer Registry. Perth: Health Department of Western Australia, 1996.
5. Threlfall T, Thompson J. Cancer incidence and mortality in Western Australia, 1995. A report of the Western Australian Cancer Registry. Perth: Health Department of Western Australia, 1997.
6. Shugg D, Dwyer T, Blizzard L. Cancer in Tasmania. Incidence and mortality 1994. Hobart: Menzies Centre for Population Health Research, 1997.
7. McCredie M, Coates M, Churches T, Rogers J. Rising incidence of prostate cancer in Australia: a result of 'screening'? J Epidemiol Biostatistics 1996; 1: 99-105.
8. Lange PH. Is screening for prostate cancer the current gold standard? - "Yes", Eur J Cancer 1997; 33: 354-356.
9. Kaye KW. Prostate cancer: enthusiasm for screening. Med J Aust 1995; 162: 540-541.
10. Kramer BS, Gohagan JK, Prorok PC. Is screening for prostate cancer the current gold standard? - "No". Eur J Cancer 1997; 33: 348-353.
11. Hirst GHL, Ward JE, Del Mar CB. Screening for prostate cancer: the case against. Med J Aust 1996; 164: 285-288.
12. Australian Health Technology Advisory Committee. Prostate cancer screening. Canberra: AGPS,1996.
13. Australian Bureau of Statistics. Estimated resident population by sex and age: States and Territories of Australia 1996. Canberra: Australian Bureau of Statistics, 1997. (Catalogue no. 3201.0.)
14. SAS [computer program]. Version 6.12. Cary, North Carolina: SAS Institute, 1996.
15. Ward JE, Gupta L, Taylor NJ. Do general practitioners use prostate-specific antigen as a screening test for early prostate cancer? Med J Aust 1998: 169; 29-31.
16. Parkes AJ, Killer GT. Prostate-specific antigen - is it already being used as a screening test? [letter]. Med J Aust 1994; 161: 722-723.
17. Ward JE, Hughes A-M, Hirst GHL, Winchester L. Men's estimates of prostate cancer risk and self-reported rates of screening. Med J Aust 1997; 167: 250-253.
18. Stephenson RA, Smart CR, Mineau GP, et al. The fall in incidence of prostate carcinoma. On the down side of a prostate specific antigen induced peak in incidence - data from the Utah Cancer Registry. Cancer 1996; 77: 1342-1348.
19. Jacobsen SJ, Katusic SK, Bergstralh EJ, et al. Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing. JAMA 1995; 274: 1445-1449.
20. Merrill RM, Potosky AL, Feuer EJ. Changing trends in U.S. prostate cancer incidence rates. J Natl Cancer Inst 1996; 88: 1683-1685.
21. Gann PH. Interpreting recent trends in prostate cancer incidence and mortality. Epidemiology 1997; 8: 117-120.
22. Lu-Yao GL, Greenberg R. Changes in prostate cancer incidence and treatment in USA. Lancet 1994; 343: 251-254.
23. Menegoz F, Colonna M, Exbrayat C, et al. A recent increase in the incidence of prostatic carcinoma in a French population: role of ultrasonography and prostatic specific antigen. Eur J Cancer 1995; 31A: 55-58.